Gyre Therapeutics, Inc. (GYRE): EPS (Diluted)
$0.02
Year ended 2025-12-31
-12.6%
3-year compound annual growth
| Period ended | EPS (Diluted) | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $0.02 | -60.0% | 2026-03-13, From 2025-01-01 |
| 2024-12-31 | $0.05 | n/m | 2026-03-13, From 2024-01-01 |
| 2023-12-31 | -$1.41 | n/m | 2025-03-17, From 2023-01-01 |
| 2022-12-31 | $0.03 | n/m | 2024-03-27, From 2022-01-01 |
| 2021-12-31 | -$2.87 | n/a | 2023-03-30, From 2021-01-01 |
| No annual figure between 2012-12-31 and 2021-12-31. | |||
| 2012-12-31 | -$0.21 | n/m | 2013-03-15, From 2012-01-01 |
| 2011-12-31 | -$0.27 | n/m | 2013-03-15, From 2011-01-01 |
| 2010-12-31 | $0.36 | n/m | 2013-03-15, From 2010-01-01 |
| 2009-12-31 | -$1.54 | n/a | 2012-03-06, From 2009-01-01 |
EPS (Diluted) at similar companies
| Company | Year ended | EPS (Diluted) | Change YoY |
|---|---|---|---|
| Gyre Therapeutics, Inc. (GYRE) | 2025-12-31 | $0.02 | -60.0% |
| Xencor Inc (XNCR) | 2025-12-31 | -$1.24 | n/m |
| Theravance Biopharma, Inc. (TBPH) | 2025-12-31 | $2.06 | n/m |
| Zevra Therapeutics, Inc. (ZVRA) | 2025-12-31 | $1.35 | n/m |
| Zymeworks Inc. (ZYME) | 2025-12-31 | -$1.08 | n/m |
| Lifecore Biomedical, Inc. (LFCR) | 2025-05-25 | -$1.27 | n/m |
| Siga Technologies Inc (SIGA) | 2025-12-31 | $0.32 | -61.0% |
| Karyopharm Therapeutics Inc. (KPTI) | 2025-12-31 | -$17.93 | n/m |
| Elite Pharmaceuticals Inc (ELTP) | 2026-03-31 | $0.03 | n/a |
Compare GYRE, XNCR, TBPH, ZVRA side by side · Screen every company in Pharmaceutical Preparations ↗